JF
DGX icon

Jericho Financial’s Quest Diagnostics DGX Stock Holding History

Jericho Financial’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$486K Sell
2,482
-140
-5% -$27.2K 0.31% 34
2025
Q4 		$455K Sell
2,622
-753
-22% -$137K 0.27% 35
2025
Q3 		$643K Sell
3,375
-195
-5% -$34.6K 0.39% 33
2025
Q2 		$641K Sell
3,570
-104
-3% -$18.1K 0.42% 33
2025
Q1 		$622K Sell
3,674
-236
-6% -$38.8K 0.45% 32
2024
Q4 		$590K Buy
+3,910
New +$608K 0.43% 32

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Jericho Financial's DGX Position: Q1 2026 in Review

Jericho Financial reduced its Quest Diagnostics (DGX) stake by 5.3% in Q1 2026, selling an estimated $27.2K and leaving 2,482 shares worth $486K. The position accounts for 0.31% of the portfolio, ranked #34.

Jericho Financial first reported a position in DGX in Q4 2024 and has held it in 6 quarters since. The position peaked at $643K in Q3 2025. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Jericho Financial held 2,482 shares of Quest Diagnostics worth $486K as of Q1 2026.
  • Jericho Financial sold 140 Quest Diagnostics shares in Q1 2026, an estimated $27.2K.
  • Quest Diagnostics made up 0.31% of Jericho Financial's portfolio in Q1 2026, its #34 holding.
  • Jericho Financial first reported a position in Quest Diagnostics in Q4 2024 and has held it in 6 quarters since.
  • Jericho Financial's Quest Diagnostics position peaked at $643K in Q3 2025.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Jericho Financial's 13F filing for Q1 2026, filed 29 Apr 2026.